
Lymph node ratio and preoperative CA 19-9 levels predict overall survival and recurrence-free survival in patients with resected pancreatic adenocarcinoma
Author(s) -
Sabrina Wentz,
Zhiguo Zhao,
Yu Shyr,
Chanjuan Shi,
Nipun B. Merchant,
Kay Washington,
Fang Xia,
A. Bapsi Chakravarthy
Publication year - 2012
Publication title -
world journal of gastrointestinal oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.924
H-Index - 26
ISSN - 1948-5204
DOI - 10.4251/wjgo.v4.i10.207
Subject(s) - medicine , hazard ratio , univariate analysis , adjuvant therapy , lymph node , proportional hazards model , adenocarcinoma , pancreatic cancer , oncology , stage (stratigraphy) , gastroenterology , urology , cancer , surgery , multivariate analysis , confidence interval , paleontology , biology
Clinicopathologic factors predicting overall survival (OS) would help identify a subset to benefit from adjuvant therapy.